New research reveals why some oesophageal cancers are so hard to treat

Published on March 13, 2026

Research published in Science Advances has uncovered new insights into why the most aggressive oesophageal cancers are so difficult to treat and how the body’s own defence systems are helping them to thrive.
Continue reading on website
Other news

Oxford and Serum Institute of India sign IP license agreement to advance NipahB vaccine candidate

March 13, 2026
The University of Oxford and Serum Institute of India Pvt. Ltd. (SII), a Cyrus Poonawalla Group company and the world’s largest vaccine manufacturer, have signed an Intellectual Property license agreement to advance the development and manufacture of the ChAdOx1 NipahB vaccine candidate.

International trial finds rapid diagnostic testing alone does not reduce antibiotic prescribing for respiratory infections

March 17, 2026
Two international studies, a clinical trial led by the University of Oxford and University of Utrecht, and a qualitative study led by the University of Oxford and University of Antwerp, report that point-of-care diagnostic testing, when used alone is unlikely to reduce antibiotic prescribing for respiratory tract infections in primary care. The findings indicate that testing must be embedded withi